Apnimed, Inc., a pharmaceutical company developing an oral drug product candidate, AD109, that is designed to address a root cause of obstructive sleep apnea (OSA), today announced that Shionogi & Co.
Asian Paints, Shriram Finance, Titan Company, Interglobe Aviation, Grasim Industries were among major gainers on the Nifty.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results